MedPath
NMPA Approval

Sodium Hyaluronate Eye Drops

国药准字H20254427

June 3, 2025

Drug Information

玻璃酸钠滴眼液

眼用制剂

0.3%(0.4ml:1.2mg)

化学药品

June 3, 2025

Company Information

Applicant Company

江西省南昌市新建区长堎外商投资工业区物华路258号

Manufacturing Company

浙江省金华市婺城区汤溪镇永湖街788号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

玻璃酸钠滴眼液 - NMPA 批准文号 | MedPath